Journals
Publish with us
Publishing partnerships
About us
Blog
Chemotherapy Research and Practice
Table of Contents
Special Issues
Chemotherapy Research and Practice
/
2012
/
Article
/
Fig 1
/
Review Article
Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management
Figure 1
Treatment recommendations for EGFRI-associated rash. Adapted from Lynch et al. 2007 [
45
].